Search Ontology:
ChEBI

amisulpride

Term ID
CHEBI:64045
Synonyms
  • 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
  • 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide
  • 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
  • Aminosultopride
  • amisulprida
  • amisulpride
  • amisulpridum
Definition
A member of the class of benzamides resulting from the formal condensation of the carboxy group of 4-amino-5-(ethylsulfonyl)-2-methoxybenzoic acid with the primary amino group of 2-(aminomethyl)-1-ethylpyrrolidine. It is a potent, selective dopamine D2 and D3 receptor antagonist. It is an atypical antipsychotic/antischizophrenic agent with limited extrapyrimidal side effects.
References
  • cas:71675-85-9
  • drugbank:DB06288
  • drugcentral:179
  • hmdb:HMDB0015633
  • kegg.drug:D07310
  • lincs.smallmolecule:LSM-1669
  • patent:BE872585
  • patent:US4401822
  • pubmed:21176108
  • pubmed:21647545
  • pubmed:21663752
  • pubmed:21746752
  • pubmed:21822161
  • pubmed:21845006
  • pubmed:21852060
  • pubmed:21886905
  • pubmed:21888613
  • pubmed:21969105
  • pubmed:22035899
  • pubmed:22059694
  • pubmed:22121864
  • pubmed:22241281
  • pubmed:22250612
  • reaxys:6876191
  • wikipedia.en:Amisulpride
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from amisulpride
Phenotype where environments contain amisulpride
Phenotype modified by environments containing amisulpride
Phenotype affecting amisulpride
Human Disease Model